カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の癌胎児性抗原アッセイキット市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Carcinoembryonic Antigen Assay Kit Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17276）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17276
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：104
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の癌胎児性抗原アッセイキット市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

癌胎児性抗原アッセイキット市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の癌胎児性抗原アッセイキットの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

癌胎児性抗原アッセイキット市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・化学発光法、微粒子酵素免疫測定法

用途別セグメントは次のように区分されます。
・病院、薬局、教育・研究機関、その他

世界の癌胎児性抗原アッセイキット市場の主要な市場プレーヤーは以下のとおりです。
・Siemens、Abbott Ireland Diagnostics Limited、Roche Diagnostics GmbH、Danaher、Biomatik、RayBiotech, Inc.、LifeSpan BioSciences、Biorbyt、OriGene Technologies、Aviva Systems Biology Corporation

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、癌胎児性抗原アッセイキット製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な癌胎児性抗原アッセイキットメーカーの企業概要、2019年～2022年までの癌胎児性抗原アッセイキットの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な癌胎児性抗原アッセイキットメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別癌胎児性抗原アッセイキットの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの癌胎児性抗原アッセイキットの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での癌胎児性抗原アッセイキット市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および癌胎児性抗原アッセイキットの産業チェーンを掲載しています。
・第13、14、15章では、癌胎児性抗原アッセイキットの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 癌胎児性抗原アッセイキットの概要
- 種類別分析（2017年vs2021年vs2028年）：化学発光法、微粒子酵素免疫測定法
- 用途別分析（2017年vs2021年vs2028年）：病院、薬局、教育・研究機関、その他
- 世界の癌胎児性抗原アッセイキット市場規模・予測
- 世界の癌胎児性抗原アッセイキット生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Siemens、Abbott Ireland Diagnostics Limited、Roche Diagnostics GmbH、Danaher、Biomatik、RayBiotech, Inc.、LifeSpan BioSciences、Biorbyt、OriGene Technologies、Aviva Systems Biology Corporation
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：化学発光法、微粒子酵素免疫測定法
・用途別分析2017年-2028年：病院、薬局、教育・研究機関、その他
・癌胎児性抗原アッセイキットの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・癌胎児性抗原アッセイキットのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・癌胎児性抗原アッセイキットのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・癌胎児性抗原アッセイキットの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・癌胎児性抗原アッセイキットの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Carcinoembryonic Antigen Assay Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Carcinoembryonic Antigen Assay Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Carcinoembryonic Antigen Assay Kit global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemiluminescence Method segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Carcinoembryonic Antigen Assay Kit include Siemens, Abbott Ireland Diagnostics Limited, Roche Diagnostics GmbH, Danaher, and Biomatik, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Carcinoembryonic Antigen Assay Kit market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemiluminescence Method
Microparticle enzyme-linked Immunoassay
Market segment by Application can be divided into
Hospital
Pharmacy
Teaching and Research Institutions
Other
The key market players for global Carcinoembryonic Antigen Assay Kit market are listed below:
Siemens
Abbott Ireland Diagnostics Limited
Roche Diagnostics GmbH
Danaher
Biomatik
RayBiotech, Inc.
LifeSpan BioSciences
Biorbyt
OriGene Technologies
Aviva Systems Biology Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Carcinoembryonic Antigen Assay Kit product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carcinoembryonic Antigen Assay Kit, with price, sales, revenue and global market share of Carcinoembryonic Antigen Assay Kit from 2019 to 2022.
Chapter 3, the Carcinoembryonic Antigen Assay Kit competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carcinoembryonic Antigen Assay Kit breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Carcinoembryonic Antigen Assay Kit market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Carcinoembryonic Antigen Assay Kit.
Chapter 13, 14, and 15, to describe Carcinoembryonic Antigen Assay Kit sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Carcinoembryonic Antigen Assay Kit Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Carcinoembryonic Antigen Assay Kit Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Chemiluminescence Method
1.2.3 Microparticle enzyme-linked Immunoassay
1.3 Market Analysis by Application
1.3.1 Overview: Global Carcinoembryonic Antigen Assay Kit Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Teaching and Research Institutions
1.3.5 Other
1.4 Global Carcinoembryonic Antigen Assay Kit Market Size & Forecast
1.4.1 Global Carcinoembryonic Antigen Assay Kit Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Carcinoembryonic Antigen Assay Kit Sales in Volume (2017-2028)
1.4.3 Global Carcinoembryonic Antigen Assay Kit Price (2017-2028)
1.5 Global Carcinoembryonic Antigen Assay Kit Production Capacity Analysis
1.5.1 Global Carcinoembryonic Antigen Assay Kit Total Production Capacity (2017-2028)
1.5.2 Global Carcinoembryonic Antigen Assay Kit Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Carcinoembryonic Antigen Assay Kit Market Drivers
1.6.2 Carcinoembryonic Antigen Assay Kit Market Restraints
1.6.3 Carcinoembryonic Antigen Assay Kit Trends Analysis
2 Manufacturers Profiles
2.1 Siemens
2.1.1 Siemens Details
2.1.2 Siemens Major Business
2.1.3 Siemens Carcinoembryonic Antigen Assay Kit Product and Services
2.1.4 Siemens Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott Ireland Diagnostics Limited
2.2.1 Abbott Ireland Diagnostics Limited Details
2.2.2 Abbott Ireland Diagnostics Limited Major Business
2.2.3 Abbott Ireland Diagnostics Limited Carcinoembryonic Antigen Assay Kit Product and Services
2.2.4 Abbott Ireland Diagnostics Limited Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche Diagnostics GmbH
2.3.1 Roche Diagnostics GmbH Details
2.3.2 Roche Diagnostics GmbH Major Business
2.3.3 Roche Diagnostics GmbH Carcinoembryonic Antigen Assay Kit Product and Services
2.3.4 Roche Diagnostics GmbH Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business
2.4.3 Danaher Carcinoembryonic Antigen Assay Kit Product and Services
2.4.4 Danaher Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biomatik
2.5.1 Biomatik Details
2.5.2 Biomatik Major Business
2.5.3 Biomatik Carcinoembryonic Antigen Assay Kit Product and Services
2.5.4 Biomatik Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 RayBiotech, Inc.
2.6.1 RayBiotech, Inc. Details
2.6.2 RayBiotech, Inc. Major Business
2.6.3 RayBiotech, Inc. Carcinoembryonic Antigen Assay Kit Product and Services
2.6.4 RayBiotech, Inc. Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 LifeSpan BioSciences
2.7.1 LifeSpan BioSciences Details
2.7.2 LifeSpan BioSciences Major Business
2.7.3 LifeSpan BioSciences Carcinoembryonic Antigen Assay Kit Product and Services
2.7.4 LifeSpan BioSciences Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biorbyt
2.8.1 Biorbyt Details
2.8.2 Biorbyt Major Business
2.8.3 Biorbyt Carcinoembryonic Antigen Assay Kit Product and Services
2.8.4 Biorbyt Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 OriGene Technologies
2.9.1 OriGene Technologies Details
2.9.2 OriGene Technologies Major Business
2.9.3 OriGene Technologies Carcinoembryonic Antigen Assay Kit Product and Services
2.9.4 OriGene Technologies Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Aviva Systems Biology Corporation
2.10.1 Aviva Systems Biology Corporation Details
2.10.2 Aviva Systems Biology Corporation Major Business
2.10.3 Aviva Systems Biology Corporation Carcinoembryonic Antigen Assay Kit Product and Services
2.10.4 Aviva Systems Biology Corporation Carcinoembryonic Antigen Assay Kit Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Carcinoembryonic Antigen Assay Kit Breakdown Data by Manufacturer
3.1 Global Carcinoembryonic Antigen Assay Kit Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Carcinoembryonic Antigen Assay Kit Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Carcinoembryonic Antigen Assay Kit
3.4 Market Concentration Rate
3.4.1 Top 3 Carcinoembryonic Antigen Assay Kit Manufacturer Market Share in 2021
3.4.2 Top 6 Carcinoembryonic Antigen Assay Kit Manufacturer Market Share in 2021
3.5 Global Carcinoembryonic Antigen Assay Kit Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Carcinoembryonic Antigen Assay Kit Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Carcinoembryonic Antigen Assay Kit Market Size by Region
4.1.1 Global Carcinoembryonic Antigen Assay Kit Sales in Volume by Region (2017-2028)
4.1.2 Global Carcinoembryonic Antigen Assay Kit Revenue by Region (2017-2028)
4.2 North America Carcinoembryonic Antigen Assay Kit Revenue (2017-2028)
4.3 Europe Carcinoembryonic Antigen Assay Kit Revenue (2017-2028)
4.4 Asia-Pacific Carcinoembryonic Antigen Assay Kit Revenue (2017-2028)
4.5 South America Carcinoembryonic Antigen Assay Kit Revenue (2017-2028)
4.6 Middle East and Africa Carcinoembryonic Antigen Assay Kit Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Carcinoembryonic Antigen Assay Kit Sales in Volume by Type (2017-2028)
5.2 Global Carcinoembryonic Antigen Assay Kit Revenue by Type (2017-2028)
5.3 Global Carcinoembryonic Antigen Assay Kit Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Carcinoembryonic Antigen Assay Kit Sales in Volume by Application (2017-2028)
6.2 Global Carcinoembryonic Antigen Assay Kit Revenue by Application (2017-2028)
6.3 Global Carcinoembryonic Antigen Assay Kit Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2028)
7.2 North America Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2028)
7.3 North America Carcinoembryonic Antigen Assay Kit Market Size by Country
7.3.1 North America Carcinoembryonic Antigen Assay Kit Sales in Volume by Country (2017-2028)
7.3.2 North America Carcinoembryonic Antigen Assay Kit Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2028)
8.2 Europe Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2028)
8.3 Europe Carcinoembryonic Antigen Assay Kit Market Size by Country
8.3.1 Europe Carcinoembryonic Antigen Assay Kit Sales in Volume by Country (2017-2028)
8.3.2 Europe Carcinoembryonic Antigen Assay Kit Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2028)
9.2 Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2028)
9.3 Asia-Pacific Carcinoembryonic Antigen Assay Kit Market Size by Region
9.3.1 Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Carcinoembryonic Antigen Assay Kit Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2028)
10.2 South America Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2028)
10.3 South America Carcinoembryonic Antigen Assay Kit Market Size by Country
10.3.1 South America Carcinoembryonic Antigen Assay Kit Sales in Volume by Country (2017-2028)
10.3.2 South America Carcinoembryonic Antigen Assay Kit Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2028)
11.2 Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2028)
11.3 Middle East & Africa Carcinoembryonic Antigen Assay Kit Market Size by Country
11.3.1 Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Carcinoembryonic Antigen Assay Kit Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Carcinoembryonic Antigen Assay Kit and Key Manufacturers
12.2 Manufacturing Costs Percentage of Carcinoembryonic Antigen Assay Kit
12.3 Carcinoembryonic Antigen Assay Kit Production Process
12.4 Carcinoembryonic Antigen Assay Kit Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Carcinoembryonic Antigen Assay Kit Typical Distributors
13.3 Carcinoembryonic Antigen Assay Kit Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Carcinoembryonic Antigen Assay Kit Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Carcinoembryonic Antigen Assay Kit Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Siemens Basic Information, Manufacturing Base and Competitors
Table 4. Siemens Major Business
Table 5. Siemens Carcinoembryonic Antigen Assay Kit Product and Services
Table 6. Siemens Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Abbott Ireland Diagnostics Limited Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Ireland Diagnostics Limited Major Business
Table 9. Abbott Ireland Diagnostics Limited Carcinoembryonic Antigen Assay Kit Product and Services
Table 10. Abbott Ireland Diagnostics Limited Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Diagnostics GmbH Basic Information, Manufacturing Base and Competitors
Table 12. Roche Diagnostics GmbH Major Business
Table 13. Roche Diagnostics GmbH Carcinoembryonic Antigen Assay Kit Product and Services
Table 14. Roche Diagnostics GmbH Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Danaher Basic Information, Manufacturing Base and Competitors
Table 16. Danaher Major Business
Table 17. Danaher Carcinoembryonic Antigen Assay Kit Product and Services
Table 18. Danaher Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biomatik Basic Information, Manufacturing Base and Competitors
Table 20. Biomatik Major Business
Table 21. Biomatik Carcinoembryonic Antigen Assay Kit Product and Services
Table 22. Biomatik Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. RayBiotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. RayBiotech, Inc. Major Business
Table 25. RayBiotech, Inc. Carcinoembryonic Antigen Assay Kit Product and Services
Table 26. RayBiotech, Inc. Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 28. LifeSpan BioSciences Major Business
Table 29. LifeSpan BioSciences Carcinoembryonic Antigen Assay Kit Product and Services
Table 30. LifeSpan BioSciences Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 32. Biorbyt Major Business
Table 33. Biorbyt Carcinoembryonic Antigen Assay Kit Product and Services
Table 34. Biorbyt Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. OriGene Technologies Basic Information, Manufacturing Base and Competitors
Table 36. OriGene Technologies Major Business
Table 37. OriGene Technologies Carcinoembryonic Antigen Assay Kit Product and Services
Table 38. OriGene Technologies Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Aviva Systems Biology Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Aviva Systems Biology Corporation Major Business
Table 41. Aviva Systems Biology Corporation Carcinoembryonic Antigen Assay Kit Product and Services
Table 42. Aviva Systems Biology Corporation Carcinoembryonic Antigen Assay Kit Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Carcinoembryonic Antigen Assay Kit Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Carcinoembryonic Antigen Assay Kit Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Carcinoembryonic Antigen Assay Kit, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Carcinoembryonic Antigen Assay Kit Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Carcinoembryonic Antigen Assay Kit Production Site of Key Manufacturer
Table 48. Carcinoembryonic Antigen Assay Kit New Entrant and Capacity Expansion Plans
Table 49. Carcinoembryonic Antigen Assay Kit Mergers & Acquisitions in the Past Five Years
Table 50. Global Carcinoembryonic Antigen Assay Kit Sales by Region (2017-2022) & (K Units)
Table 51. Global Carcinoembryonic Antigen Assay Kit Sales by Region (2023-2028) & (K Units)
Table 52. Global Carcinoembryonic Antigen Assay Kit Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Carcinoembryonic Antigen Assay Kit Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2022) & (K Units)
Table 55. Global Carcinoembryonic Antigen Assay Kit Sales by Type (2023-2028) & (K Units)
Table 56. Global Carcinoembryonic Antigen Assay Kit Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Carcinoembryonic Antigen Assay Kit Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Carcinoembryonic Antigen Assay Kit Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Carcinoembryonic Antigen Assay Kit Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2022) & (K Units)
Table 61. Global Carcinoembryonic Antigen Assay Kit Sales by Application (2023-2028) & (K Units)
Table 62. Global Carcinoembryonic Antigen Assay Kit Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Carcinoembryonic Antigen Assay Kit Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Carcinoembryonic Antigen Assay Kit Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Carcinoembryonic Antigen Assay Kit Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Carcinoembryonic Antigen Assay Kit Sales by Country (2017-2022) & (K Units)
Table 67. North America Carcinoembryonic Antigen Assay Kit Sales by Country (2023-2028) & (K Units)
Table 68. North America Carcinoembryonic Antigen Assay Kit Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Carcinoembryonic Antigen Assay Kit Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2022) & (K Units)
Table 71. North America Carcinoembryonic Antigen Assay Kit Sales by Type (2023-2028) & (K Units)
Table 72. North America Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2022) & (K Units)
Table 73. North America Carcinoembryonic Antigen Assay Kit Sales by Application (2023-2028) & (K Units)
Table 74. Europe Carcinoembryonic Antigen Assay Kit Sales by Country (2017-2022) & (K Units)
Table 75. Europe Carcinoembryonic Antigen Assay Kit Sales by Country (2023-2028) & (K Units)
Table 76. Europe Carcinoembryonic Antigen Assay Kit Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Carcinoembryonic Antigen Assay Kit Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2022) & (K Units)
Table 79. Europe Carcinoembryonic Antigen Assay Kit Sales by Type (2023-2028) & (K Units)
Table 80. Europe Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2022) & (K Units)
Table 81. Europe Carcinoembryonic Antigen Assay Kit Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Carcinoembryonic Antigen Assay Kit Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Carcinoembryonic Antigen Assay Kit Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales by Application (2023-2028) & (K Units)
Table 90. South America Carcinoembryonic Antigen Assay Kit Sales by Country (2017-2022) & (K Units)
Table 91. South America Carcinoembryonic Antigen Assay Kit Sales by Country (2023-2028) & (K Units)
Table 92. South America Carcinoembryonic Antigen Assay Kit Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Carcinoembryonic Antigen Assay Kit Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2022) & (K Units)
Table 95. South America Carcinoembryonic Antigen Assay Kit Sales by Type (2023-2028) & (K Units)
Table 96. South America Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2022) & (K Units)
Table 97. South America Carcinoembryonic Antigen Assay Kit Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Carcinoembryonic Antigen Assay Kit Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Carcinoembryonic Antigen Assay Kit Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales by Application (2023-2028) & (K Units)
Table 106. Carcinoembryonic Antigen Assay Kit Raw Material
Table 107. Key Manufacturers of Carcinoembryonic Antigen Assay Kit Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Carcinoembryonic Antigen Assay Kit Typical Distributors
Table 111. Carcinoembryonic Antigen Assay Kit Typical Customers
List of Figures
Figure 1. Carcinoembryonic Antigen Assay Kit Picture
Figure 2. Global Carcinoembryonic Antigen Assay Kit Revenue Market Share by Type in 2021
Figure 3. Chemiluminescence Method
Figure 4. Microparticle enzyme-linked Immunoassay
Figure 5. Global Carcinoembryonic Antigen Assay Kit Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Teaching and Research Institutions
Figure 9. Other
Figure 10. Global Carcinoembryonic Antigen Assay Kit Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Carcinoembryonic Antigen Assay Kit Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Carcinoembryonic Antigen Assay Kit Sales (2017-2028) & (K Units)
Figure 13. Global Carcinoembryonic Antigen Assay Kit Price (2017-2028) & (US$/Unit)
Figure 14. Global Carcinoembryonic Antigen Assay Kit Production Capacity (2017-2028) & (K Units)
Figure 15. Global Carcinoembryonic Antigen Assay Kit Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Carcinoembryonic Antigen Assay Kit Market Drivers
Figure 17. Carcinoembryonic Antigen Assay Kit Market Restraints
Figure 18. Carcinoembryonic Antigen Assay Kit Market Trends
Figure 19. Global Carcinoembryonic Antigen Assay Kit Sales Market Share by Manufacturer in 2021
Figure 20. Global Carcinoembryonic Antigen Assay Kit Revenue Market Share by Manufacturer in 2021
Figure 21. Carcinoembryonic Antigen Assay Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Carcinoembryonic Antigen Assay Kit Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Carcinoembryonic Antigen Assay Kit Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Carcinoembryonic Antigen Assay Kit Sales Market Share by Region (2017-2028)
Figure 25. Global Carcinoembryonic Antigen Assay Kit Revenue Market Share by Region (2017-2028)
Figure 26. North America Carcinoembryonic Antigen Assay Kit Revenue (2017-2028) & (USD Million)
Figure 27. Europe Carcinoembryonic Antigen Assay Kit Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Carcinoembryonic Antigen Assay Kit Revenue (2017-2028) & (USD Million)
Figure 29. South America Carcinoembryonic Antigen Assay Kit Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Carcinoembryonic Antigen Assay Kit Revenue (2017-2028) & (USD Million)
Figure 31. Global Carcinoembryonic Antigen Assay Kit Sales Market Share by Type (2017-2028)
Figure 32. Global Carcinoembryonic Antigen Assay Kit Revenue Market Share by Type (2017-2028)
Figure 33. Global Carcinoembryonic Antigen Assay Kit Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Carcinoembryonic Antigen Assay Kit Sales Market Share by Application (2017-2028)
Figure 35. Global Carcinoembryonic Antigen Assay Kit Revenue Market Share by Application (2017-2028)
Figure 36. Global Carcinoembryonic Antigen Assay Kit Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Carcinoembryonic Antigen Assay Kit Sales Market Share by Type (2017-2028)
Figure 38. North America Carcinoembryonic Antigen Assay Kit Sales Market Share by Application (2017-2028)
Figure 39. North America Carcinoembryonic Antigen Assay Kit Sales Market Share by Country (2017-2028)
Figure 40. North America Carcinoembryonic Antigen Assay Kit Revenue Market Share by Country (2017-2028)
Figure 41. United States Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Carcinoembryonic Antigen Assay Kit Sales Market Share by Type (2017-2028)
Figure 45. Europe Carcinoembryonic Antigen Assay Kit Sales Market Share by Application (2017-2028)
Figure 46. Europe Carcinoembryonic Antigen Assay Kit Sales Market Share by Country (2017-2028)
Figure 47. Europe Carcinoembryonic Antigen Assay Kit Revenue Market Share by Country (2017-2028)
Figure 48. Germany Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Carcinoembryonic Antigen Assay Kit Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Carcinoembryonic Antigen Assay Kit Revenue Market Share by Region (2017-2028)
Figure 57. China Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Carcinoembryonic Antigen Assay Kit Sales Market Share by Type (2017-2028)
Figure 64. South America Carcinoembryonic Antigen Assay Kit Sales Market Share by Application (2017-2028)
Figure 65. South America Carcinoembryonic Antigen Assay Kit Sales Market Share by Country (2017-2028)
Figure 66. South America Carcinoembryonic Antigen Assay Kit Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Carcinoembryonic Antigen Assay Kit Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Carcinoembryonic Antigen Assay Kit Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Carcinoembryonic Antigen Assay Kit Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Carcinoembryonic Antigen Assay Kit in 2021
Figure 78. Manufacturing Process Analysis of Carcinoembryonic Antigen Assay Kit
Figure 79. Carcinoembryonic Antigen Assay Kit Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の癌胎児性抗原キャリブレータ市場2022年：市場規模予測（～2028年）
  • 世界の細胞増殖アッセイキット市場2022年：市場規模予測（～2028年）
  • 前立腺特異抗原（PSA）半定性キットのグローバル市場展望 2023年-2029年：診断用前立腺特異抗原（PSA）半定性キット、研究用前立腺特異抗原（PSA）半定性アッセイキット
  • アデノウイルス抗原迅速検出キットのグローバル市場展望 2023年-2029年：蛍光定量法、金コロイド法
  • アフリカ豚熱抗原迅速検出キットのグローバル市場展望 2023年-2029年：蛍光定量法、金コロイド法
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17276 )"世界の癌胎児性抗原アッセイキット市場2022年：市場規模予測（～2028年）" (英文：Global Carcinoembryonic Antigen Assay Kit Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。